$OKYO Pharma (OKYO.US)$ OKYO Pharma Says OK-101 Achieves Sta...
$OKYO Pharma(OKYO.US$ OKYO Pharma Says OK-101 Achieves Statistical Significance For Multiple Signs And Symptoms Of Dry Eye Disease Including Ocular Pain Relief In Its First-in-Human Phase 2 Trial Of OK-101
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment